Protective Effect of KRP-101, Novel PPARα Agonist, on Fatty Liver Disease Through Induction of Lipid Oxidation & Suppression of Lipogenesis in Hamsters.
- Published in:
- Diabetes, 2007, v. 56, p. A131
- By:
- Publication type:
- Article
Works by Akasaka, Yunike
Results: 2
1
2
Highly Sensitive and Potent Upregulation of Apolipoprotein A-IV/V by Novel PPARα Agonist, KRP-101, as Major PPARα-Regulated Genes in Human Hepatocytes.
- Published in:
- Diabetes, 2007, v. 56, p. A56
- By:
- Publication type:
- Article